Alcubierre Rafel, Sánchez-Dalmau Bernardo F, Muñoz Silvia
Departamento de Oftalmología, Hospital Moisès Broggi Sant Joan Despi, Consorci Sanitari Integral, Barcelona, España.
Institut Clínic d'Oftalmologia (ICOF), Hospital Clínic, Barcelona, España.
Med Clin (Barc). 2020 Jul 24;155(2):70-76. doi: 10.1016/j.medcli.2020.02.009. Epub 2020 May 11.
Disorders of the visual system are one of the main features of multiple sclerosis (MS), and have a great impact on the quality of life of patients. Although optic neuritis is the most frequent manifestation, there are other ophthalmological processes not related to neuritis, a knowledge of which is very useful in the management of patients with MS. These abnormalities are described, grouped into impairments of the afferent pathway, efferent pathway, or upper cerebral areas. Additionally, the main ophthalmological side effects of the drugs currently used in the control of MS are described.
视觉系统障碍是多发性硬化症（MS）的主要特征之一，对患者的生活质量有很大影响。虽然视神经炎是最常见的表现，但还有其他与神经炎无关的眼科病症，了解这些病症对MS患者的管理非常有用。本文描述了这些异常情况，并将其分为传入通路、传出通路或大脑上部区域的损伤。此外，还描述了目前用于控制MS的药物的主要眼科副作用。
